Earnings Call · Q3 FY2025·2025-10-30

Q3 25EPS +21.43%·Rev n/aQ2 25EPS +7.69%·Rev n/aQ1 25EPS +32.61%·Rev n/aQ4 24EPS -69.44%·Rev n/a⚠ consensus missing

NovoCure Ltd NVCR

Ingrid Goldberg — Unknown

William Doyle — Executive Chairman

Ashley Cordova — Chief Executive Officer

Christoph Brackmann — Chief Financial Officer

−4.9%1d on move date−3.8% vs SPY3d−9.3%5d−13.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NVCR calls or request research access.

More NVCR calls Browse calls Request research access